🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Radial vs Vena No-Touch Assessment

RecruitingNAAges 18 Years - anyFemaleTomsk Cardiology Research Institute
NCT07552948 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study examines the outcomes of coronary artery bypass grafting (CABG) in women at 1 year after surgery. A randomized controlled trial is planned, including a comparative analysis of two observed groups depending on the chosen conduit for revascularization of the circumflex artery. The main group is supposed to include 55 patients undergoing CABG with the use of the radial artery, while the control group will include 55 patients undergoing CABG with the use of the great saphenous vein prepared using the no-touch technique.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Three-vessel disease involving the target circumflex artery with stenosis ≥70% and a diameter ≥1.5 mm 2. Females aged 18 years and older 3. Signed informed consent 4. Clinical indications for coronary revascularization (refractory angina/transient myocardial ischemia according to noninvasive tests) Exclusion Criteria: 1. Previous cardiac surgery of any type, including CABG 2. Combined procedures 3. Ineligibility for venous or radial artery harvesting as determined by preoperative Doppler flowmetry or clinical examination that would compromise graft patency. 4. Acute myocardial ischemia 5. EF less than 35% 6. CKD 4.5 7. Inability to understand the nature, scope, and consequences of the clinical trial, or to provide written informed consent due to cognitive impairment or mental illness. 8. Life expectancy less than 1 year due to non-cardiac diseases.
💊

What it tests

  • radial artery graft
  • no-touch vein graft
📍

Where

1 site
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
Tomsk, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy